<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03586102</url>
  </required_header>
  <id_info>
    <org_study_id>300000681</org_study_id>
    <nct_id>NCT03586102</nct_id>
  </id_info>
  <brief_title>Effect of Increased Enteral Protein on Body Composition of Preterm Infants</brief_title>
  <official_title>Effect of Increased Enteral Protein on Body Composition of Preterm Infants: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Health System, Alabama</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that, in human milk-fed extremely preterm infants, higher protein
      intake compared to usual protein intake reduces percent body fat (%BF) at 3 months of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Qualifying participants will be randomly assigned to receive either standard protein
      supplementation (control group) or high protein supplementation (intervention group).

      Intervention group: A fixed amount of commercially available hydrolyzed bovine protein will
      be added to fortified human milk after establishment of full enteral feeding.

      Control group: Hydrolyzed bovine protein will not be added to fortified human milk after
      establishment of full enteral feeding.

      If parent agrees, stool &quot;dirty&quot; diapers will be collected 2 times (at the time of hospital
      discharge and at 3 months of corrected age).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 23, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Clinicians and technicians responsible for the assessment of infant body composition will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Infant body composition</measure>
    <time_frame>Assessed at 3 months of corrected age</time_frame>
    <description>Percent body fat estimated by air displacement plethysmography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infant body composition</measure>
    <time_frame>Assessed at 36 weeks of postmenstrual age or hospital discharge (whichever occurs first)</time_frame>
    <description>Percent body fat estimated by air displacement plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth</measure>
    <time_frame>Birth to 3 months of corrected age</time_frame>
    <description>Weekly weight gain in grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length</measure>
    <time_frame>Birth to 3 months of corrected age</time_frame>
    <description>Weekly length in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head circumference</measure>
    <time_frame>Birth to 3 months of corrected age</time_frame>
    <description>Weekly head circumference in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>Birth to 3 months of corrected age</time_frame>
    <description>Weight and height will be combined to report BMI in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing enterocolitis</measure>
    <time_frame>Postnatal day 14 to postnatal day 120 or discharge, whichever occurs first</time_frame>
    <description>Number of participants with diagnosis of necrotizing enterocolitis stage 2 or 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>Postnatal day 14 to postnatal day 120 or discharge, whichever occurs first</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in intestinal microbiome</measure>
    <time_frame>Birth to 3 months of corrected age</time_frame>
    <description>Determined by molecular analyses of bacteria in fecal samples</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in metabolic pathways</measure>
    <time_frame>Birth to 3 months of corrected age</time_frame>
    <description>Determined by molecular analyses of serum samples</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Premature Infant</condition>
  <arm_group>
    <arm_group_label>High protein supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infants will receive a diet that consists of mother's own milk or donor human milk and bovine-based human milk fortifier plus a fixed amount of commercially available hydrolyzed bovine protein. The study intervention will begin the day after fortification is ordered and will be continued until postnatal day 50 or 32 weeks postmenstrual age, whichever occurs first.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard protein supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants will receive a standard diet that consists of mother's own milk or donor human milk (DHM) and bovine-based human milk fortifier. The study intervention will be continued until postnatal day 50 or 32 weeks postmenstrual age, whichever occurs first.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High protein supplementation</intervention_name>
    <description>To increase protein content of human milk, a fixed amount of commercially available hydrolyzed bovine protein will be added to fortified human milk. With this pragmatic approach, preterm infants assigned to the high protein supplementation group will receive &gt; 4.5 g/kg/day of enteral protein after establishment of full enteral feeding.</description>
    <arm_group_label>High protein supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standard protein supplementation</intervention_name>
    <description>Infants assigned to the standard protein supplementation group will receive fortified human milk (&lt; 4.5 g/kg/day of enteral protein)</description>
    <arm_group_label>Standard protein supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age between 25 and 28 weeks of gestation

          -  Feeding volumes of â‰¥120 ml/kg/day before or on postnatal day 14.

        Exclusion Criteria:

          -  Necrotizing enterocolitis (NEC) stage 2 or greater.

          -  Gastrointestinal or neurologic malformations.

          -  Terminal illness needing to limit or withhold support will be exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ariel A. Salas, MD, MSPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ariel A. Salas, MD, MSPH</last_name>
    <phone>205-934-4680</phone>
    <email>asalas@peds.uab.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariel A. Salas, MD, MSPH</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 1, 2018</study_first_submitted>
  <study_first_submitted_qc>July 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2018</study_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Ariel A. Salas, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Protein supplementation</keyword>
  <keyword>Human milk fortification</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

